Jane Street Group LLC Buys Shares of 61,811 Alpha Teknova, Inc. (NASDAQ:TKNO)

Jane Street Group LLC purchased a new position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 61,811 shares of the company's stock, valued at approximately $516,000. Jane Street Group LLC owned approximately 0.12% of Alpha Teknova as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its stake in shares of Alpha Teknova by 622.5% during the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after buying an additional 3,791 shares during the last quarter. Mount Lucas Management LP bought a new stake in shares of Alpha Teknova during the fourth quarter worth approximately $75,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Alpha Teknova during the fourth quarter worth approximately $94,000. NewEdge Advisors LLC raised its stake in shares of Alpha Teknova by 14.3% during the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock worth $131,000 after buying an additional 1,953 shares during the last quarter. Finally, Barclays PLC bought a new stake in shares of Alpha Teknova during the fourth quarter worth approximately $132,000. Institutional investors and hedge funds own 13.81% of the company's stock.

Alpha Teknova Trading Up 0.3%

Shares of TKNO traded up $0.02 on Tuesday, reaching $5.75. 313,717 shares of the company's stock were exchanged, compared to its average volume of 398,719. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $307.29 million, a P/E ratio of -7.77 and a beta of 0.50. The business has a 50 day moving average price of $5.96 and a two-hundred day moving average price of $7.04. Alpha Teknova, Inc. has a 12 month low of $1.16 and a 12 month high of $10.37.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. The firm had revenue of $9.60 million during the quarter, compared to the consensus estimate of $9.41 million. Research analysts anticipate that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Craig Hallum began coverage on shares of Alpha Teknova in a research note on Monday, February 10th. They set a "buy" rating and a $12.00 price target for the company.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.